According to the previous studies, some laboratory findings such as lymphopenia, neutropenia, increased alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), high-sensitivity C-reactive protein (hs-CRP), and some clinical signs such as myalgia and shortness of breath had a relationship with an increased mortality and could also be considered as risk factors for COVID-19 mortality (7, 8). This evidence concerns the gene GPT and Decreased total neutrophil count.